| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 1.7e-05 | 1 |